Events  Classes  Deals  Spaces  Jobs  SXSW 2018 
    Sign in  
 
 
With Kate Merton (Head of JLABS, Johnson & Johnson Innovation), Maria Gotsch (Founder/CEO, Partnership Fund for NYC), Andrew ElBardissi (Principal, Deerfield Mgmt), Misti Ushio (CEO, TARA Biosystems).
Monday, February 12, 2018 at 03:30 PM    Cost: $25
New York Genome Center, 101 6th Ave
 
     
 
 
              

              

 
Sign up for our awesome New York
Tech Events weekly email newsletter.
   
LOCATION
DETAILS
In the past NYC hasn't always felt the love for its reputation on being an innovation hotspot with many still considering San Francisco & Cambridge at the heart of healthcare innovation, especially when it comes to the start-up space. But in true New York fashion the City has quickly grown to become the epicenter of the reinvention of healthcare as we know it. At JLABS @ NYC, we invite you to join us for a panel session focused on why 2018 is going to be a critical year for further growth & opportunities in the region for innovation in the life sciences space. You'll hear diverse perspectives ranging from the investment space to the entrepreneur's side of the house. The insights & advice shared will be truly inspiring & can help propel your journey as an entrepreneur forward. Participating Representatives: Kate Merton | Head of JLABS @ NYC, Johnson & Johnson Innovation, JLABS read bio Maria G. Gotsch | Founder & CEO Partnership Fund for New York read bio Andrew ElBardissi | Principal on Private Transaction Team, Deerfield Management read bio Misti Ushio | CEO, TARA Biosystems read bio Agenda: 03:30 PM | Registration Opens & Networking 04:00 PM | Presentation & Q&A 05:00 PM | Networking Session 06:00 PM | Program Close Fees: Presentation & Lunch $25 | General Public $35 | At the door Includes presentation, Q&A, & refreshments. Venue: New York Genome Center 101 6th Ave. New York, NY 10013 Map it Speakers' Biographies:
Kate Merton Ph.D.| Head of JLABS @ NYC, Johnson & Johnson Innovation, JLABS As Head of Johnson & Johnson Innovation, JLABS in New York, Kate is responsible for external engagement, innovation sourcing, company onboarding, portfolio management, operational excellence, educational programming & P&L. She catalyzes & supports the translation of science & technology into valuable solutions for patients & consumers across the pharmaceutical, medical device, consumer & healthtech sectors. Kate joins JLABS with 15 years of experience working across the Healthcare industry, starting in R&D before moving onto roles in Marketing, Business Development, External Alliances, Medical Affairs, Health Outcomes & most recently Disruptive Innovation. During her career Kate has been part of teams that have discovered new drugs, worked to develop & gain approval for blockbuster diabetes products & is passionate about being part of the future of healthcare where science intersects with the rapid advancements in health care technology Kate holds an undergraduate degree in Pharmacology & Toxicology from King's College London, & a PhD in Pharmacology & Toxicology from University of California, Irvine Medical School. She received her MBA from the Fuqua School of Business at Duke University.
^ Back to speakers' list ^
Maria Gotsch | Founder & CEO, Partnership Fund for New York
Maria is the President & CEO at the Partnership Fund for New York City, which is the investment arm of the Partnership for New York City. In addition to leading the Fund's operations, Maria has spearheaded the creation & operation of a number of the Fund's strategic initiatives, including: FinTech Innovation Lab; New York Digital Health Accelerator; Fashion Tech Lab; NYCSeed (seed financing for IT/digital media companies); BioAccelerate Prize NYC (proof-of-concept funding for university-based biomedical research); Arts Entrepreneurial Loan Fund (low cost loans for mid-size arts groups); & ReStart Central & Financial Recovery Fund (assistance & funding for small businesses impacted by 9/11/01). Prior to joining the Fund in 1999, Maria was a Managing Director at BT Wolfensohn (now part of Deutsche Bank), providing strategic & financial advice related to mergers, acquisitions, dispositions, joint ventures & the development of business strategies. Before starting with Wolfensohn, Maria worked at LaSalle Partners in the New York area & for Merrill Lynch Capital Markets in New York & London. Maria has an MBA from Harvard Business School & a BA from Wellesley College. She was also the recipient of a Fulbright Fellowship to study international relations at the Institut Universitaire de Hautes Etudes Internationales in Geneva, Switzerland. .
^ Back to speakers' list ^
Andrew ElBardissi | Principal on Private Transaction, Deerfield
Dr. ElBardissi is a Principal on the Private Transaction team at Deerfield Management. Prior to joining Deerfield, Dr. ElBardissi held roles as an early stage life-sciences investor at Longitude Capital & as an Investment Banker at J.P. Morgan's Healthcare practice. Dr. ElBardissi holds an M.D. from the Mayo Clinic, an M.P.H. in Quantitative Methods from Harvard University, an M.B.A. from Harvard Business School. He received residency training in General Surgery at Harvard Medical School's Brigham & Women's Hospital & in Cardiothoracic Surgery at Stanford University. Dr. ElBardissi has been independently funded by the National Institutes of Health (NIH) & the Agency for Healthcare Research & Quality (AHRQ), has over 30 publications in leading peer reviewed scientific journals, & has presented his research at numerous medical & surgical conferences. He currently serves on the Boards of Neochord, SentreHeart, Acutus, Iowa Approach, Conventus & is Board Chair of M-trap
^ Back to speakers' list ^
.
^ Back to speakers' list ^
Misti Ushio Ph.D. | CEO, TARA Biosystem
Misti Ushio, PhD. is the founding CEO of TARA Biosystems. Dr. Ushio has over 20 years of experience in the biotechnology & pharmaceutical industry, & early stage life science company building. Dr. Ushio has served most recently as Chief Strategy Officer & Managing Director of Harris & Harris Group, where she advised & invested in life science companies to help them translate their transformational science into commercially successful companies. Earlier in her career, Dr. Ushio held management roles at Merck & Company, where she developed vaccines & biologics products, & Columbia University, where she managed the intellectual property of several scientific & engineering portfolios. She was graduated from Johns Hopkins University (B.S., Chemical Engineering), Lehigh University (M.S., Chemical Engineering) & University College London (Ph.D., Biochemical Engineering). She also serves as a Director on the Boards of private & public life science companies.
 
 
 
 
© 2018 GarysGuide      About   Terms   Press   Feedback